产品详情
张福利研究员
张福利博士:上海医药工业研究院研究员,博士生导师,复旦大学、浙江工业大学兼职教授。长期从事药物重大品种工艺研究和化学创新药物研究,研究领域涉及心脑血管疾病、老年痴呆、哮喘、肿瘤、真菌感染、免疫抑制剂等治疗药物的基础研究和应用开发研究,尤其在手性药物的不对称合成以及重大品种的产业化方面形成技术优势,先后负责50余项课题的研制开发。在国内外期刊发表论文30余篇,参与编写专著1部,申请发明专利54项(授权23项)。已培养博士生6名,硕士生30名。2010年获得上海市优秀学科带头人称号。为国家“新药创制”重大专项(化学组)责任专家,全国医药产业节能环保专业委员会副主任。

题目:绿色制药工艺研发 Green Pharmaceutical Process Research and Development

上海医药工业研究院,张福利研究员Shanghai Institute of Pharmaceutical Industry, Professor Zhang Fuli

张福利博士:上海医药工业研究院研究员,博士生导师,复旦大学、浙江工业大学兼职教授。长期从事药物重大品种工艺研究和化学创新药物研究,研究领域涉及心脑血管疾病、老年痴呆、哮喘、肿瘤、真菌感染、免疫抑制剂等治疗药物的基础研究和应用开发研究,尤其在手性药物的不对称合成以及重大品种的产业化方面形成技术优势,先后负责50余项课题的研制开发。在国内外期刊发表论文30余篇,参与编写专著1部,申请发明专利54项(授权23项)。已培养博士生6名,硕士生30名。2010年获得上海市优秀学科带头人称号。为国家“新药创制”重大专项(化学组)责任专家,全国医药产业节能环保专业委员会副主任。

Dr. Zhang Fuli: professor in Shanghai Institute of Pharmaceutical Industry, doctoral supervisor, adjunct professor in Fudan University and Zhejiang University of Technology. He has long been engaged in the research for pharmaceutical process of major varieties and innovative chemical drugs. His study fields involve basic research and applied research of drugs for cardiovascular and cerebrovascular diseases, Alzheimer's disease, asthma, cancer, fungal infection and Immunosuppression. He has formed obvious technical advantages in asymmetric synthesis of the chiral drugs and industrialization of major varieties, and has been responsible for more than 50 projects. He has published more than 30 papers, cooperative edited one monograph, and applied for 54 patents (23 patents authorized). Has trained 6 doctoral, 30 master's students. He was named excellent academic leaders of Shanghai in 2010. He is specialist for the" National Drug Discovery Major Projects” (chemical group). He is deputy director of the professional committee of national pharmaceutical industry energy conservation and environmental protection.

底部编辑